Akoustis Technologies (AKTSQ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on November 21, 2024, to address key governance and business matters.
Stockholders will vote on director elections, executive compensation, a reverse stock split, and auditor ratification.
The Board recommends voting in favor of all proposals and director nominees.
The reverse stock split aims to maintain Nasdaq listing compliance and improve stock marketability.
Voting matters and shareholder proposals
Six directors are nominated for one-year terms expiring at the 2025 annual meeting.
Advisory vote on executive compensation is included, with annual frequency.
Proposal to amend the certificate of incorporation for a reverse stock split at a ratio between 1-for-50 and 1-for-250, to be selected by the Board.
Ratification of Marcum LLP as independent auditor for fiscal year ending June 30, 2025.
No other business is anticipated at the meeting.
Board of directors and corporate governance
Board consists of six members, with a majority deemed independent under Nasdaq rules.
Leadership structure separates CEO and Co-Chairmen roles for independent oversight.
Board committees include Audit, Compensation, Nominating, Technology, and IT Governance.
Board diversity matrix and code of ethics are disclosed.
Directors are encouraged to attend annual meetings; all attended in 2023.
Latest events from Akoustis Technologies
- Key votes include director elections, a reverse stock split, and auditor ratification.AKTSQ
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, a reverse stock split, and auditor ratification.AKTSQ
Proxy Filing1 Dec 2025 - Annual Meeting adjourned for lack of quorum; voting extended to December 12, 2024.AKTSQ
Proxy Filing1 Dec 2025 - Annual meeting adjourned for lack of quorum; voting extended to January 9, 2025.AKTSQ
Proxy Filing1 Dec 2025 - Shareholders to vote on a reverse split as Nasdaq grants conditional continued listing.AKTSQ
Proxy Filing1 Dec 2025 - Kingsdale was engaged to assist with proxy solicitation for the 2024 annual meeting.AKTSQ
Proxy Filing1 Dec 2025 - Severe litigation losses and asset impairments drove Akoustis to a $167.9M net loss and liquidity crisis.AKTSQ
Q4 202413 Jun 2025 - Litigation-driven liquidity crisis threatens Akoustis' survival despite improved operating results.AKTSQ
Q1 202513 Jun 2025